TABLE 2.

Clinical and virological characteristics of patients before and after therapy

Sample	Genotype	Viral load (IU/ml)		ALT level (U/liter)		AST level (U/liter)		ALP level (U/liter)		Response
		BT	AT	BT	AT	BT	AT	BT	AT
1	3b	1,231,000	BDL	52	28	59	19	288	220	Fast
2	3b	162,000	293,000	76	63	84	72	320	280	None
3	1a	391,000	171,000	61	42	67	47	295	228	None
4	1b	693,000	231,000	121	29	117	33	228	234	None
5	3b	282,000	BDL	44	21	51	18	292	198	Fast
6	3b	782,000	BDL	94	32	105	37	388	370	Fast
7	1a	687,000	24,100	125	31	200	29	299	196	None
8	3b	341,000	9,000	36	31	46	37	299	480	Slow
9	1a	471,000	BDL	18	18	26	26	235	197	Slow
10	1a	341,000	BDL	63	31	71	35	276	192	Slow
11	1b	706,000	313,000	63	21	58	26	310	298	None
12	3b	451,000	BDL	54	17	51	21	223	210	Slow
13	1b	373,000	BDL	81	05	93	07	403	220	Slow
14	1a	1,355,000	BDL	121	32	108	35	191	286	Slow
15	1a	231,000	BDL	31	32	28	35	281	295	Fast